dihexa lyophilized powder stability – 10MG Diaphorase lyophilized powder, main 3.0-20.0units/mg

Landmark Achievement: CagriSema has produced mean weight loss exceeding 20% in Phase 3 trials, approaching the efficacy of bariatric surgery without invasive procedures

Novo Nordisk originally planned a dual-chamber pen, but recent studies confirmed the drug works well in a single-chamber FlexTouch pen, the same device Ozempic uses

Thymosin Beta are peptide is created from Thymosin beta 4

This being said, it would be great to see full data, hopefully including changes in body composition and physical fitness - if not here, then perhaps in some later trials Looking forward to full data presentation and also to further trials looking into possible cardioprotective and nephroprotective effects and influence on other complications of obesity #cagrisema #tirzepatide #cagrilintide #semaglutide #obesity #weightloss #REDEFINE4 To view or add a comment, sign in More Relevant Posts As a next-generation combination, CagriSema was widely expected to at least match tirzepatides efficacy in REDEFINE-4